Dr. Aart A. van Apeldoorn

Dr. Aart A. van Apeldoorn is an Assistant Professor and currently holds a position as a principal investigator in the MERLN institute for technology-inspired regenerative medicine at Maastricht University in the Netherlands, and has an affilitated position in the MIRA Institute at the University of Twente and the University Medical Center Groningen (UMCG). There, he leads the Islet Research Group, which aims to develop a bioartificial pancreas for extrahepatic islet transplantation. Dr van Apeldoorn is currently the Chairman of the Steering Committee for the Diabetes Cell Therapy Initiative and maintains a number of international and national collaborations. He received his PhD in 2005 at University of Twente, Enschede. Before starting the Islet Research Group, Dr van Apeldoorn was CEO and Founder of MicroCandela Systems and the project leader on a Dutch Platform for Tissue Engineering project on Raman imaging for tissue engineering, and he worked in the bone tissue engineering team at IsoTis (now part of Integra LifeSciences).